Fig. 1From: Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitorsMild and severe skin toxicity (ST) are both associated with improved PFS and OS in advanced cancer patients treated with ICI. a Progression-free survival (PFS) and b overall survival (OS) by ST grouping. All p-values are from the log-rank testsBack to article page